Nuvaira

company

About

Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases.

  • 1 - 10

Details

Last Funding Type
Series E
Last Funding Money Raised
$79M
Industries
Biotechnology,Health Care,Information Technology,Medical Device
Founded date
Jan 1, 2008
Number Of Employee
1 - 10
Operating Status
Active

Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases. Nuvaira is currently working on a novel catheter-based system that has the potential to improve lung function, exercise capacity, and quality of life for patients with chronic obstructive pulmonary disease.

It was founded in 2008 and headquartered in Minneapolis, Minnesota.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$144.60M
Nuvaira has raised a total of $144.60M in funding over 2 rounds. Their latest funding was raised on Feb 11, 2019 from a Series E round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 11, 2019 Series E $79M 1 Detail
Apr 3, 2014 Series D $42M 1 Detail
Feb 8, 2013 Series C $10M 1 Detail
Sep 20, 2012 Series B $10.60M 1 Detail
Sep 29, 2010 Series A $3M 1 Versant Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Nuvaira is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series E